News

Etienne Guyot, state prefect for the regions of Occitanie and the Haute-Garonne, and Didier Codorniou, first vice-president of the region of Occitanie and the Mediterranean-Pyrenees, handed over the prize to the winners of the Call for Proposals entitled “Avenir...

This infographic allows you to discover to what extent hearing loss is linked to other health conditions and what are important risk factors.

CILcare will be attending the 56th IEB Workshop taking place in Pradua, Italy, from 7 to 10 September, 2019. Feel free to join Gaelle NAERT, Ph.D, Chief Operations Officer, to learn more about our services in the field of hearing. Poster presentations: "Comparison of...

CILcare will be attending the 17th Annual Discovery on Target on September 16-19, 2019 in Boston. Meet Sylvie PUCHEU, Ph.D, CSO, with her presentation on Preclinical approaches to develop treatment for tinnitus on 17th of September at 11:55 AM (Lead Generation...

CILcare will attend the Nordic Life Science Days on September 10-12, 2019 in Malmö. Meet Dr. Wahid AWAD, Director of Business Strategy and Alliances, to learn more about CILcare’s offer to support your drug developement in ear disorders. Please do not hesitate to...

CILcare was created in July 2014 by three managers from Sanofi, Celia Belline, Dr. Marie-Pierre Pasdelou and Dr. Sylvie Pucheu, who combined their skills to accelerate the development of innovate medical treatments for hearing disorders, including hearing loss,...

CILcare will attend the 2nd Annual Neuropsychiatric Drug Development Summit on July 24-25, 2019 in Boston. Meet Dr. Gaëlle NAERT, COO to know more about the link between hearing & neuropsychiatric disorders! Please do not hesitate to contact us to schedule a...

Meet CILcare at the Annual meeting of preclinical research AFSSI Connexions on July 2-3, 2019 in Lyon. Join Celia Belline, CEO, Dr. Sylvie Pucheu, CSO, and Dr. Wahid Awad, Director of Business Strategy and Alliances, at our booth to learn more about CILcare’s offer to...